Production and characterization of LEA29Y, a variant of cytotoxic T-lymphocyte antigen 4-immunoglobulin, in Pichia pastoris (Q39550211)

13 September 2017

title

Production and characterization of LEA29Y, a variant of cytotoxic T-lymphocyte antigen 4-immunoglobulin, in Pichia pastoris (English)

1 reference

13 September 2017

Pichia pastoris

1 reference

Lin Wan

1

1 reference

13 September 2017

Shengyun Zhu

2

1 reference

13 September 2017

Yingying Li

3

1 reference

13 September 2017

Shan Liu

4

1 reference

13 September 2017

Hao Yang

5

1 reference

13 September 2017

Shengfu Li

6

1 reference

13 September 2017

Youping Li

7

1 reference

13 September 2017

Jingqiu Cheng

8

1 reference

13 September 2017

Xiaofeng Lu

9

1 reference

13 September 2017

language of work or name

English

0 references

publication date

28 April 2011

1 reference

Applied Microbiology and Biotechnology

13 September 2017

published in

1 reference

13 September 2017

volume

91

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

543-551

1 reference

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Recombinant protein expression in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Expression in the yeast Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Production of recombinant proteins by microbes and higher organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Advances in immunosuppression for renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Process technology for production and recovery of heterologous proteins with Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Sialylation enhancement of CTLA4-Ig fusion protein in Chinese hamster ovary cells by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

The glycosylation and pharmacokinetics of CTLA4Ig produced in rice cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Costimulatory pathways in transplantation: challenges and new developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

The clinical utility of inhibiting CD28-mediated costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

CD28 and CTLA-4 coreceptor expression and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Strategic opportunities in clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Cloning, expression and bioassay of canine CTLA4Ig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Five-year safety and efficacy of belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3277-4

10.1007/S00253-011-3277-4

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference